Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic
© Pereira et al.; licensee BioMed Central Ltd. 2013
Received: 26 October 2012
Accepted: 17 April 2013
Published: 20 April 2013
The antibody Ki-67 is a reliable and easy tool to accurately assess the growth fraction of neoplasms in humans and animals, and it has been used to predict the clinical outcome. Therefore, the aim of the present study was to investigate the immunohistochemical expression pattern of Ki-67 in normal and neoplastic perianal glands of dogs to evaluate the possible use of this proliferation marker as an ancillary method of perianal tumor diagnosis. We studied 42 cases of perianal gland neoplasms including adenomas (n = 15), epitheliomas (n = 15), and carcinomas (n = 12). As controls, 13 tissue samples from normal perianal glands were used. A Ki-67 index was established by a computer-assisted image analysis and compared with manual counting.
Out of the 42 cases of perianal gland neoplasms, 34 were from males and eight from females. Recurrence was reported in 14 cases, being higher (8/12) in carcinomas. Immunostaining for Ki-67 revealed that the carcinomas showed a higher proliferation rate (9.87%) compared to groups of epitheliomas (2.66%) and adenomas (0.36%). For adenomas and epitheliomas of the perianal glands the computer-assisted counting and the manual counting gave similar results; however, only the computer-assisted image analysis was efficient to predict the perianal gland carcinoma recurrence.
Since there were significant differences in the number of Ki-67-positive nuclei, this marker proved to be effective in helping the classification of perianal gland neoplasms and to refine the diagnosis criteria, especially in those samples with high variation in morphology/area. Also, higher Ki-67 index is related to recurrence in cases of perianal gland carcinomas. Further, the computer-assisted image analysis proved to be a fast and reliable method to assess the Ki-67 index in perianal gland neoplasms.
KeywordsCell proliferation Computer-assisted image analysis Dogs Immunohistochemistry MIB-1
Perianal glands, also known as circumanal glands (by their location) and hepatoid glands (by their histological similarity with hepatocytes), are modified sebaceous glands present primarily in perianal skin .
Tumors of perianal glands are common in intact and aged male dogs. They occur occasionally in females and rarely in neutered males [2, 3]. The causes of these neoplasms are unknown; however, gonadal hormones appear to interfere with perianal gland cell proliferation [1, 3]. The possible influence of testosterone in perianal gland neoplasms is indicated by the high prevalence of benign tumor regression (up to 95%) after male neutering [1–4].
Adenoma is a common lesion in dogs and, besides hyperplasia, accounts for 8-10% of all canine skin tumors . Adenomas generally retain the lobular architecture, presenting well-differentiated hepatoid cells and a single peripheral layer of basaloid reserve cells . Some adenomas contain focal areas of pleomorphism that may suggest malignant transformation .
Several authors have grouped perianal gland epitheliomas with perianal gland adenomas [4, 6], but the World Health Organization classified adenomas and epitheliomas in different categories . Walder and Gross  classified the epitheliomas as low-grade perianal gland carcinomas. Distinction between adenomas and epitheliomas is easy when the basaloid reserve cells are organized in sheets, islands or trabeculae, together with moderate-low to moderate-high mitosis index, without atypia .
Perianal gland carcinomas are uncommon canine malignant neoplasms and occur almost exclusively in a perianal location. Well-differentiated carcinomas are clinically indistinguishable from adenomas. They are characterized by nodular formation. On the other hand, poorly differentiated carcinomas are poorly circumscribed and usually ulcerated . The cells in well-differentiated carcinomas maintain the hepatoid morphology, forming solid islands and tightly packed trabaculae with a scarcity of collagen. The maturation patterns from reserve cells to hepatoid cells are disorganized and reserve cells are increased in number . The distinction between perianal adenoma and carcinoma is often difficult: both may have poorly preserved lobulation and intermingling of germinal cells with mature hepatoid cells .
The Ki-67 antigen is expressed in G1, S, G2, and M phases of the cell cycle, but not in G0, and thus Ki-67 distinguishes between proliferating and quiescent cells . Ki-67 expression is usually estimated as percentage of immunostained cells, with nuclear staining being the most common criterion for proliferative index . Ki-67 is tightly controlled and regulated, implying a fundamental role in cell proliferation . Further, the primary antibody anti-human Ki-67 (clone MIB-1) has been extensively used in studies to determine the prognosis of several types of canine neoplasms [12–14].
Although the morphological pattern of perianal gland neoplasms, when observed using hematoxylin and eosin stain (HE), is supposed to allow an accurate diagnosis, occasionally, the occurrence of focal pleomorphism in adenomas and epitheliomas can suggest malignant transformation, and result in recurrence. Therefore, the aim of this study was to investigate the immunohistochemical pattern of Ki-67 staining in normal and neoplastic canine perianal glands in order to evaluate the possible use of this proliferation marker as an ancillary method to determine perianal tumor diagnosis and prognosis.
This study was approved by the Institutional Ethics and Animal Welfare Committee (Comissão de Ética no Uso de Animais - CEUA, UNESP, process number 02214-2011).
Forty-two canine perianal gland neoplasms were retrieved from the archives of a private practice laboratory of veterinary pathology (VETPAT – Campinas – São Paulo- Brazil). The owners were contacted and asked to answer a questionnaire regarding identification of the animals, evolution of the case, and recurrence. The specimens were re-evaluated by two pathologists. All specimens were removed during surgery, fixed in 10% neutral buffer formalin, embedded in paraffin, and consecutive sections were used for histology (HE) and immunohistochemistry.
The diagnosis of perianal gland neoplasia was recognized on HE-stained tissue sections following the criteria established by the World Health Organization (WHO) for glandular tumors of domestic animals . The tumors examined included perianal gland adenomas (n = 15), epitheliomas (n = 15), and carcinomas (n = 12). All specimens were obtained from dogs having the neoplasm removed for the first time, i.e., no recurrent tumor was included. Normal perianal glands were obtained from dogs that were euthanized or died from other conditions (n = 13).
5-μm thick sections were mounted on poly-L-lysine-coated slides, dewaxed, and rehydrated. Antigen retrieval was performed with citrate buffer (pH 6.0) in a microwave oven for 30 min. Endogenous peroxidase activity was blocked by incubating the sections in 2% (v/v) hydrogen peroxide (30 vol) diluted in 50% (v/v) methanol for 30 min. Subsequently, non-specific binding was blocked with 3% (w/v) non-fat dried milk in phosphate-buffered saline (PBS) pH 7.2 for 30 min. Sections were then incubated with the monoclonal mouse anti-human Ki-67 antibody (clone MIB-1, M7240, Dako), diluted 1:100 for 18–22 h at 4°C in a humidified chamber. The sections were subsequently washed in PBS and incubated with a biotinylated secondary antibody followed by the streptavidin-horseradish-peroxidase complex, in accordance with the manufacturer’s instructions (LSAB + Kit, K0690, Dako). The reaction was developed using 3,3'-diaminobenzidine (K3468, Dako). The slides were then counterstained with Harris’s hematoxylin, dehydrated, cleared, and mounted with coverslips. Negative controls were obtained by omitting the primary antibody. Positive controls included adjacent normal skin (basal cells) in each slide.
Computer-assisted image analysis
The differences among groups were determined by the Kruskal-Wallis test followed by Dunn’s multiple comparison test. For recurrence analyses, the Mann Whitney test was used. A value of P < 0.05 was considered statistically significant. Data are expressed as the median (minimum-maximum). A ROC (receiver operating characteristic) curve was used to determine the cut-off value for recurrence in perianal gland carcinomas, using the Ki-67 index obtained from the computer-assisted image analysis. All statistical analyses were performed using Prism 6 software (GraphPad).
Data from dogs included in the experimental groups
Total of cases
Recurrence (n° of cases)
5 - 13
8 - 24
8 - 15
6 - 36
3 - 12
4 - 24
The adenomas were characterized by the presence of epithelial cells with abundant and eosinophilic cytoplasm, low pleomorphism, and basal cells with small and hyperchromatic nuclei. The cells were organized in islands separated by well-vascularized connective tissue (Figure 2A).
The epitheliomas were organized in lobules made up of epithelial cells with abundant and eosinophilic cytoplasm and low pleomorphism. The presence of basaloid cells with large nucleus, loose chromatin, evident nucleolus, and occasional mitosis was noted. Cell islands separated by connective tissue were also present (Figure 2C). In some samples, focal areas of squamous metaplasia were noted, and also areas with high-grade anaplasia, suggesting malignant transition.
In carcinomas, the noticed proliferation pattern was cribriform. The cells presented a large and clear nucleus, loose chromatin, evident nucleolus, cytoplasm with poorly defined borders, and frequent mitosis (Figure 2E).
Proliferation is a key feature of tumor progression and Ki-67 staining is a convenient method for assessing cell proliferation, applicable in most laboratories for humans [15, 17] and animals [12–14]. The results presented here show that Ki-67 detection reflects the proliferation index of each type of perianal gland tumor. The Ki-67 index decreased from malignant towards benign lesions, with carcinomas presenting the highest Ki-67 index, which was useful to help the classification of the neoplasms, at least in less-differentiated samples. These findings are in agreement with previous studies using AgNOR (argyrophilic proteins related to nucleolar organizer regions) . Similar to Ki-67, AgNOR is related to the proliferative activity of neoplasms and it may be associated with aggressive biological behavior – however, although the number of AgNORs increases in malignancy, the ability of this marker to define malignancy is still controversial .
In the routine diagnosis of perianal gland tumors, the use of HE staining generally allows an accurate diagnosis and the correct classification of adenomas, epitheliomas and carcinomas. However, in epitheliomas, areas with elevated anaplasia were frequently observed, suggesting transition to high-grade carcinomas. The use of proliferation markers, such as Ki-67, may help to confirm these differences and refine diagnostic criteria, particularly for well-differentiated perianal gland carcinomas .
Data relative to gender, age range, evolution time, and recurrence are in conformity with the available literature about perianal glands neoplasms in dogs . Recurrence was related in eight out of 12 dogs with perianal gland carcinomas, in three dogs with epitheliomas, and three with adenomas. This disagreement among diagnosis and tumor behavior was previously described by Berrocal et al. , who observed recurrence in six out of 23 cases designated as “moderately or poorly differentiated” perianal gland adenomas, which included epitheliomas as well as low-grade carcinomas. Moreover, the recurrence in adenomas and epitheliomas may also have occurred due to neoplastic tissue remaining even after the surgical excision of the tumor. Regarding carcinomas, the samples with the highest Ki-67 indexes were taken from dogs that presented tumor recurrence, allowing us to suggest that the Ki-67 index, assessed by computer-assisted image analysis, may be used as a predictor of risk of recurrence, as also observed in other neoplasms [21–23].
Currently, there is a widely accepted use of Ki-67 to evaluate cell proliferation in cancer, but there is no standard protocol. One important factor that could bias the determination of the Ki-67 index is the subjective determination of the Ki-67 immunostained area. In the recent recommendations from the International Ki-67 in Breast Cancer Working Group , the authors stated that the Ki-67 evaluation method can be based on three patterns of Ki-67 immunostaining: homogeneous, hot spots, and a gradient of increasing staining toward the tumor edge; however, the most commonly used method to calculate the Ki-67 index is based on the hot spots, which also includes studies of prognostic value [12–14, 22]. The recommendations from the same group  classified as ‘unknown’ which Ki-67 scoring method, manual (visual) or computer-assisted (automated), is superior. Despite being different types of neoplasms, based on the results presented herein, we provide evidence that the computer-assisted method is superior, at least in canine perianal gland tumors.
Finally, this study established that the immunohistochemical detection of Ki-67 may help the morphological classification of more complex canine perianal gland neoplasms and it is helpful to better predict the risk of recurrence. The computer-assisted image analysis was demonstrated to be more accurate and a less time-consuming technique to evaluate the Ki-67 index, especially by facilitating the analysis where there is cell overlap or accumulation, when compared to manual counting. These results strongly suggest that a higher proliferation index is related to the aggressiveness of neoplastic cells and these differences must be taken into account to achieve a diagnosis and to establish the best therapeutic protocol.
GF Machado is recipient of funding from the CNPq (Brazil’s National Council of Technological and Scientific Development). A Schweigert and GD Melo are supported by FAPESP (São Paulo Research Foundation) doctoral fellowships.
- Gross TL, Ihrke P, Walder EJ, Affolter VK, Blackwell O: Sebaceous tumors. Skin diseases of the Dog and Cat. Clinical and Histopathologic Diagnosis. Edited by: Gross TL, Ihrke P, Walder EJ, Affolter VK, Blackwell O. 2005, Oxford: Blackwell Science, 625-648. 2View ArticleGoogle Scholar
- Withrow SJ: Perianal tumors. Small animal clinical oncology. Edited by: Withrow SJ, Macewen EG. 2001, Philadelphia: Saunders, 346-353. 3Google Scholar
- Yager JA, Scott DW: The skin and appendages. Pathology of domestic animals. Edited by: Jubb KVF, Kennedy PC, Palmer N. 1993, San Diego: Academic, 531-738. 4View ArticleGoogle Scholar
- Goldschmidt MH, Hendrick MJ: Tumors of the skin and soft tissues. Tumors in domestic animals. Edited by: Meuten DJ. 2002, Iowa: Ames, 44-117. 4Google Scholar
- Ganguly A, Wolfe LG: Canine perineal gland carcinoma-associated antigen defined by monoclonal antibodies. Hybridoma. 2006, 25: 10-14. 10.1089/hyb.2006.25.10.PubMedView ArticleGoogle Scholar
- Pulley LT, Stannard AA: Tumors of the skin and soft tissues. Tumors in domestic animals. Edited by: Moulton JE. 1990, Berkeley: University of California, 23-87.Google Scholar
- Goldschmidt MH, Dunstan RW AAS, Von Tscharner C, Walder EJ, Yager JA: Histological Classification of Epithelial and Melanocytic Tumors of the Skin of Domestic Animals. 1998, Washington: Armed Forces Institute of Pathology, 2Google Scholar
- Walder EJ, Gross TL: Epithelial tumors. Veterinary Dermatopathology: A macroscopic and microscopic evaluation of canine and feline skin disease. Edited by: Gross TL, Ihrke PJ, Walder EJ. 1992, Boston: Mosby, 329-520.Google Scholar
- Gerdes J, Schlueter CLL, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H: Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991, 138: 867-873.PubMedPubMed CentralGoogle Scholar
- Taneja P, Maglic D, Kai F, Zhu S, Kending RD, Fry EA, Inoue K: Classical and novel prognostic markers for breast cancer and theis clinical significance. Clin Med Insights Oncol. 2010, 4: 15-34.PubMedPubMed CentralGoogle Scholar
- Brown D, Gatter K: Ki67 protein: the immaculate deception?. Histopathology. 2002, 40: 2-11. 10.1046/j.1365-2559.2002.01343.x.PubMedView ArticleGoogle Scholar
- Bergin IL, Smedley RC, Esplin DG, Spangler WL, Kiupel M: Prognostic Evaluation of Ki67 Threshold Value in Canine Oral Melanoma. Vet Pathol. 2011, 48 (1): 41-53. 10.1177/0300985810388947.PubMedView ArticleGoogle Scholar
- Peña LL, Nieto AI, Pérez-Alenza D, Cuesta P, Castaño M: Immunohistochemical Detection of Ki-67 and PCNA in Canine Mammary Tumors: Relationship to Clinical and Pathologic Variables. J Vet Diagn Invest. 1998, 10 (3): 237-246. 10.1177/104063879801000303.PubMedView ArticleGoogle Scholar
- Webster JD, Yuzbasiyan-Gurkan V, Miller RA, Kaneene JB, Kiupel M: Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication. Vet Pathol. 2007, 44 (3): 298-308. 10.1354/vp.44-3-298.PubMedView ArticleGoogle Scholar
- Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG: Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000, 13 (8): 900-908. 10.1038/modpathol.3880161.PubMedView ArticleGoogle Scholar
- Melo GD, Machado GF: Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres. Cell Tissue Res. 2011, 346 (3): 293-304. 10.1007/s00441-011-1290-7.PubMedView ArticleGoogle Scholar
- Urruticoechea A, Smith IE, Dowsett M: Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005, 23: 7212-7220. 10.1200/JCO.2005.07.501.PubMedView ArticleGoogle Scholar
- Preziosi R: Della Salda L, Ricci P, Sikoni P, Marcato PS: Quantification of nuclear organiser regions in canine perianal gland tumours. Res Vet Sci. 1995, 58: 277-281. 10.1016/0034-5288(95)90117-5.PubMedView ArticleGoogle Scholar
- Sivrides E, Anastasiadis P, Von Ludinghausen M: Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions?. Zentralbl Pathol. 1992, 138 (2): 103-107.PubMedGoogle Scholar
- Berrocal A, Vos JH, Van Den Ingh TS, Molenbeek RF, Van Sluljs FJ: Canine perineal tumours. Zentralbl Veterinarmed. 1989, 36: 739-749.View ArticleGoogle Scholar
- Abry E, Thomassen IØ, Salvesen ØO, Torp SH: The significance of Ki-67/MIB-1 labeling index in human meningiomas: A literature study. Pathol Res Pract. 2010, 206 (12): 810-815. 10.1016/j.prp.2010.09.002.PubMedView ArticleGoogle Scholar
- Bettencourt M-C, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW: Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 1996, 156 (3): 1064-1068. 10.1016/S0022-5347(01)65703-3.PubMedView ArticleGoogle Scholar
- Valente G, Orecchia R, Gandolfo S, Araudo M, Ragona R, Kerin S, Palestro G: Can Ki-67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?. J Clin Pathol. 1994, 47: 109-112. 10.1136/jcp.47.2.109.PubMedPubMed CentralView ArticleGoogle Scholar
- Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T: Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst. 2011, 103 (22): 1656-1664. 10.1093/jnci/djr393.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.